CPT 0556F: Plan of Care for Lipid Control in Coronary Artery Disease

CPT code 0556F documents that a clinician has established a plan of care to achieve lipid control for a patient with coronary artery disease (CAD). As a performance measure–style code used in quality reporting and clinical documentation, it signals that lipid management has been intentionally addressed in the patient’s care plan, which is central to secondary prevention of cardiovascular events.

Nationally, payers and quality programs track lipid control planning and outcomes as part of cardiovascular disease management. Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical intent and documentation purpose of 0556F, how payers commonly treat this type of documentation in prior authorization and quality reporting workflows, and where it fits within broader lipid-management and CAD care pathways.

This publication provides a concise clinical and policy context for 0556F, summarizes payer coverage considerations, and points to related measurement and billing topics that affect reporting and care coordination. Data not available in the input will be noted where applicable.

Billing Code Overview

CPT code 0556F indicates that a provider establishes a plan of care to achieve lipid control for a patient with coronary artery disease (CAD). This code represents documentation that a targeted lipid management plan has been created as part of the patient’s cardiovascular care.

Service type: Care planning for lipid control, counseling and treatment planning related to lipid management
Typical site of service: Outpatient clinic or ambulatory cardiology practice; may also be used in primary care settings where CAD management and lipid control planning occur

Data not available in the input.

Clinical Context

A typical patient is a 68-year-old male with known coronary artery disease (CAD) presenting for routine cardiovascular risk management. The patient has a history of myocardial infarction and percutaneous coronary intervention, current statin therapy with suboptimal LDL-C, and multiple cardiovascular risk factors (hypertension, type 2 diabetes). During a scheduled outpatient cardiology or primary care visit, the provider reviews recent lipid panel results, assesses medication adherence and side effects, evaluates drug interactions and comorbid conditions, and documents a structured plan of care to achieve lipid control. The plan includes target LDL-C goals consistent with secondary prevention guidelines, adjustments to lipid-lowering therapy (intensify statin, add ezetimibe or PCSK9 inhibitor as clinically indicated), counseling on diet and lifestyle, lab monitoring schedule, and follow-up visit arrangements. Typical workflow: review chart and labs → patient interview and medication reconciliation → clinical decision-making and documentation of the individualized lipid management plan → order medications and labs → schedule follow-up. Typical sites of service include outpatient clinic visits in cardiology offices, primary care clinics, or multidisciplinary chronic disease management programs.

Coding Specifications

Modifier	Description	When to Use
`25`	Significant, Separately Identifiable Evaluation and Management Service by the Same Physician on the Same Day of the Procedure	Use when a distinct E/M visit is performed the same day as a procedure unrelated to the lipid plan documentation.

Taxonomy Code	Specialty	Notes
207RC0000X	Cardiology	Cardiology providers commonly establish and manage lipid control plans for patients with CAD.
207Q00000X	Interventional Cardiology	Interventional cardiologists involved in secondary prevention and medication optimization after coronary intervention.
207L00000X	Internal Medicine	Primary care internists frequently develop and monitor lipid management plans for chronic CAD patients.
208D00000X	Family Medicine	Family physicians manage ongoing lipid control and coordinate lifestyle interventions.
290M00000X	Preventive Medicine	Preventive medicine specialists may design risk-reduction lipid strategies and population health plans.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`I25.10`	Atherosclerotic heart disease of native coronary artery without angina pectoris	Common diagnosis for patients with CAD who require targeted lipid control for secondary prevention.
`I25.110`	Atherosclerotic heart disease of native coronary artery with unstable angina	Indicates higher-risk CAD where aggressive lipid management is important.
`I25.9`	Chronic ischemic heart disease, unspecified	General CAD diagnosis supporting development of a lipid management plan.
`E78.5`	Hyperlipidemia, unspecified	Primary lipid disorder indication for lipid-lowering therapy and plan documentation.
`E78.0`	Pure hypercholesterolemia	Specific dyslipidemia commonly targeted by statin and non-statin therapies in CAD patients.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Common visit level used when documenting the evaluation and management portion that includes development of the lipid plan of care.
`93000`	Electrocardiogram, routine ECG with at least 12 leads; tracing and interpretation	Often obtained or reviewed during cardiovascular visits to assess overall cardiac status while managing lipid therapy.
`80061`	Lipid panel (cholesterol, HDL, LDL, triglycerides)	Essential laboratory test used to document baseline and follow-up lipid values guiding the plan of care.
`99406`	Smoking and tobacco cessation counseling, intermediate, greater than 3 minutes up to 10 minutes	Frequently provided as part of lifestyle modification counseling in the lipid control plan.
`99401`	Preventive medicine counseling, individual, for smoking cessation/nutrition (older CPT; commonly replaced by time-based counseling codes)	Represents brief counseling services included in lifestyle interventions; select appropriate preventive counseling codes per payor policy.
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	May be billed when administering injectable lipid-lowering agents (e.g., PCSK9 inhibitors) during the visit.

OpenPayer

Summary & Overview